Epidemiology Study of Keloid
Although keloid is a very common condition; there are no statistics as to its true incidence and prevalence, neither in United States, nor elsewhere in the world. This trial intends to capture epidemiological data about this disease in a large population sample.
|Study Design:||Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
|Official Title:||Epidemiology Study of Keloid|
- Prevalence of various clinical findings will be determined at the end of Survey. [ Time Frame: Two Years ] [ Designated as safety issue: No ]This will be a prospective online and paper based survey with an estimated 100,000 responders participating in two years. Statistics will be descriptive. The prevalence of various clinical findings will be determined at the end of Survey. Findings will be correlated with the source of the data, online, or paper questionnaire, as well as the locations where the paper questionnaires surveys were placed.
|Study Start Date:||September 2011|
|Estimated Study Completion Date:||December 2015|
|Estimated Primary Completion Date:||June 2015 (Final data collection date for primary outcome measure)|
The aim of this study is to determine the prevalence and incidence of keloid in large populations.
The purpose of current trial is to establish a robust database of incidence and prevalence of keloid, as well as prevalence of familial keloid, in various ethnic groups. Study sample size is 100,000 random individuals who will fill out either a web survery or a paper questionnaire.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01423383
|Contact: Michael H. Tirgan, MD||(212) 874 email@example.com|
|United States, New York|
|Michael H. Tirgan, MD||Recruiting|
|New York, New York, United States, 10023|
|Contact: Michael H. Tirgan, MD 212-874-4200 firstname.lastname@example.org|
|Principal Investigator: Michael H. Tirgan, MD|
|Study Chair:||Michael H. Tirgan, MD||St. Luke's-Roosevelt Hospital Center|